February 13, 2020: BioCentury Publications, Inc.: Vivo-led $105M round to spur development of ALX's CD47

Press/Media: Press / Media

Period2020 Feb 13

Media coverage

10

Media coverage

  • TitleFebruary 13, 2020: BioCentury Publications, Inc.: Vivo-led $105M round to spur development of ALX's CD47
    Media name/outletNews Bites - Private Companies
    CountryAustralia
    Date20/2/13
    PersonsYoung-Guen Kwon
  • TitleFebruary 13, 2020: BioCentury Publications, Inc.: Four execs set to leave Sanofi as Hudson continues reorg
    Media name/outletNews Bites - Private Companies
    CountryAustralia
    Date20/2/13
    PersonsYoung-Guen Kwon
  • TitleFebruary 13, 2020: BioCentury Publications, Inc.: Feb. 12 Financial Quick Takes: Trio of follow-ons; plus Teva, PentixaPharm, Inotrem
    Media name/outletNews Bites - Private Companies
    CountryAustralia
    Date20/2/13
    PersonsYoung-Guen Kwon
  • TitleFebruary 13, 2020: BioCentury Publications, Inc.: Catalyzing controversy: FDA emails challenge its claims that price plays no role in approvals
    Media name/outletNews Bites - Private Companies
    CountryAustralia
    Date20/2/13
    PersonsYoung-Guen Kwon
  • TitleFebruary 13, 2020: BioCentury Publications, Inc.: Feb. 12 Financial Quick Takes: Trio of follow-ons; plus Teva, PentixaPharm, Inotrem
    Media name/outletNews Bites - Private Companies
    CountryAustralia
    Date20/2/13
    PersonsYoung-Guen Kwon
  • TitleFebruary 13, 2020: BioCentury Publications, Inc.: COVID-19 update: Remdesivir readout in weeks; hospital-use diagnostic under development; antibodies advancing
    Media name/outletNews Bites - Private Companies
    CountryAustralia
    Date20/2/13
    PersonsYoung-Guen Kwon
  • TitleFebruary 13, 2020: BioCentury Publications, Inc.: Four execs set to leave Sanofi as Hudson continues reorg
    Media name/outletNews Bites - Private Companies
    CountryAustralia
    Date20/2/13
    PersonsYoung-Guen Kwon
  • TitleFebruary 13, 2020: BioCentury Publications, Inc.: COVID-19 update: Remdesivir readout in weeks; hospital-use diagnostic under development; antibodies advancing
    Media name/outletNews Bites - Private Companies
    CountryAustralia
    Date20/2/13
    PersonsYoung-Guen Kwon
  • TitleFebruary 13, 2020: BioCentury Publications, Inc.: Catalyzing controversy: FDA emails challenge its claims that price plays no role in approvals
    Media name/outletNews Bites - Private Companies
    CountryAustralia
    Date20/2/13
    PersonsYoung-Guen Kwon
  • TitleFebruary 13, 2020: BioCentury Publications, Inc.: Vivo-led $105M round to spur development of ALX's CD47
    Media name/outletNews Bites - Private Companies
    CountryAustralia
    Date20/2/13
    PersonsYoung-Guen Kwon